Ferment is a synthetic biology company creation studio that focuses on launching scalable, product-focused biotech startups. The firm partners with founders, corporate strategic partners, and investors to build market-defining companies in the synthetic biology space. Ferment leverages the economies of scale created by the biotech "tools revolution" over the past two decades.
A key partnership for Ferment is with Ginkgo Bioworks, the leading platform for cell programming. This collaboration enhances Ferment's ability to create innovative biotech companies. The firm's portfolio includes Zenso, a startup that has raised $350,000. Ferment typically invests in pre-seed rounds, supporting early-stage synthetic biology ventures with promising potential.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.